Poster – Development And Validation Of Flow Cytometry Assays For Autologous And Allogenic CAR T In Global Clinical Programs
The advancement in cell and gene therapies, particularly chimeric antigen receptor (CAR)…
Read more
CYTO 2023 Poster Pack
Comparison of BD FACSLyric™ Instrument Performance in a Global Setting As flow…
Read more
Automatization of Immunohistochemistry Data Analysis for Protocol Validation
This presentation was given by Marie Gerus-Durand, Principal Scientist & Validation Engineer…
Read more
A blood-based biomarker panel for non-invasive diagnosis of non-alcoholic steatohepatitis: a multi-centre prospective and validation study
A late-stage biopharmaceutical company dedicated to metabolic and chronic liver diseases is…
Read more
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
Discover how circulating calprotectin measurement could be a predictor of moderate COVID-19…
Read more
DECENTRALIZED CLINICAL TRIALS: FROM WORDS TO ACTION
Discover how Cerba Research is participating to set good practices for decentralized…
Read more
The Cobas AmpliPrep/Cobas TaqMan HCV Test, Version 2.0, Real-Time PCR Assay Accurately Quantifies Hepatitis C Virus Genotype 4 RNA
The aim of this study was to evaluate the ability of the…
Read more
Cell-Free DNA Analysis in Maternal Plasma in
Cases of Fetal Abnormalities Detected on
Ultrasound Examination
Discover how we help to evaluate the utility of noninvasive prenatal testing…
Read more
Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population
Discover how we help this worldwide ultra-deep sequencing based genotyping study reveals…
Read more
Detection of in vivo hepatitis B virus surface antigen mutations—A comparison of four routine screening assays
An important requirement for a state-of-the-art hepatitis B surface antigen (HBsAg) screening…
Read more
Clinical performance of three automated screening assays for antibodies against nuclear antigens
Using a defined serum panel of patients clinically diagnosed with various CTD…
Read more
EliASymphony, the first fully automated random access assay using only recombinant human antigens and a synthetic SmDpeptide to screen for autoantibodies against extractable nuclear antigens (ENA)
Using a defined serum panel of patients clinically diagnosed with CTD as…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.
Contact Us